SS Innovations International, Inc. announced on July 15, 2025, that it has installed over 100 SSi Mantra surgical robotic systems. These installations span India and six other countries, demonstrating growing global demand and acceptance for the system.
To date, more than 5,000 surgical procedures have been successfully performed using the SSi Mantra, including 240 cardiac surgeries and 32 telesurgeries. This represents a significant increase from 2,759 robotic surgeries, 151 cardiac surgeries, and 9 telesurgeries reported as of December 31, 2024.
The company attributes this growth to the SSi Mantra's premium quality, innovative features, ease of use, and cost-effectiveness. SS Innovations expects to submit a De Novo application to the U.S. Food and Drug Administration by the end of July 2025 and continues to pursue European Union CE marking certification by late 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.